{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T19:52:03Z","timestamp":1788205923912,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,3,16]],"date-time":"2013-03-16T00:00:00Z","timestamp":1363392000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Forensic Sci Med Pathol"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12024-013-9410-1","type":"journal-article","created":{"date-parts":[[2013,3,15]],"date-time":"2013-03-15T20:20:00Z","timestamp":1363378800000},"page":"218-220","source":"Crossref","is-referenced-by-count":12,"title":["Lethal neuroleptic malignant syndrome due to amisulpride"],"prefix":"10.1007","volume":"9","author":[{"given":"Frank","family":"Musshoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Doberentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Burkhard","family":"Madea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,3,16]]},"reference":[{"key":"9410_CR1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/00023210-200923060-00003","volume":"23","author":"JN Trollor","year":"2009","unstructured":"Trollor JN, Chen X, Sachdev PS. Neuroleptic malignant syndrome associated with atypical antipsychotic drugs. CNS Drugs. 2009;23:477\u201392.","journal-title":"CNS Drugs"},{"issue":"1","key":"9410_CR2","first-page":"54","volume":"20","author":"S Guzofski","year":"2006","unstructured":"Guzofski S, Peralta R. Neuroleptic malignant syndrome, with attention to its occurrence with atypical antipsychotic medication: a review. Jeff J Psych. 2006;20(1):54\u201361.","journal-title":"Jeff J Psych"},{"key":"9410_CR3","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1176\/ajp.143.12.1587","volume":"143","author":"G Addonizio","year":"1986","unstructured":"Addonizio G, Susman VL, Roth SD. Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. Am J Psychiatry. 1986;143:1587\u201390.","journal-title":"Am J Psychiatry"},{"key":"9410_CR4","unstructured":"American Psychiatric Association. Diagnostic and statistical manual. 4th ed. (text revision). Arlington, VA: American Psychiatric Publishing; 2000."},{"key":"9410_CR5","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1176\/ajp.142.10.1137","volume":"142","author":"JL Levenson","year":"1985","unstructured":"Levenson JL. Neuroleptic malignant syndrome. Am J Psychiatry. 1985;142:1137\u201345.","journal-title":"Am J Psychiatry"},{"key":"9410_CR6","first-page":"158","volume":"215","author":"F Musshoff","year":"2005","unstructured":"Musshoff F, Kr\u00f6ner L, Padosch SA, Madea B. Fatal intoxication with amisulpride and presentation of organ distribution. Arch Kriminol. 2005;215:158\u201363.","journal-title":"Arch Kriminol"},{"issue":"4","key":"9410_CR7","doi-asserted-by":"crossref","first-page":"R136","DOI":"10.1186\/cc11441","volume":"16","author":"M Schulz","year":"2012","unstructured":"Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1000 drugs and other xenobiotics. Crit Care. 2012;16(4):R136.","journal-title":"Crit Care"},{"key":"9410_CR8","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/096032719501400310","volume":"14","author":"A Tracqui","year":"1995","unstructured":"Tracqui A, Mutter-Schmidt C, Kintz P, Berton C, Mangin P. Amisulpride poisoning: a report on two cases. Hum Exp Toxicol. 1995;14:294\u20138.","journal-title":"Hum Exp Toxicol"},{"key":"9410_CR9","doi-asserted-by":"crossref","first-page":"354","DOI":"10.5694\/j.1326-5377.2006.tb00272.x","volume":"184","author":"GK Isbister","year":"2006","unstructured":"Isbister GK, Murray L, John S, Hackett LP, Haider T, O\u2019Mullane P, Gosselin S, Daly F. Amisulpride deliberate self-poisoning causing severe cardiac toxicity including QT prolongation and torsades de pointes. Med J Aust. 2006;184:354\u20136.","journal-title":"Med J Aust"},{"key":"9410_CR10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1258\/rsmmsl.48.2.173","volume":"48","author":"MJ Lynch","year":"2008","unstructured":"Lynch MJ, Woods J, George N, Gerostamoulos D. Fatality due to amisulpride toxicity: a case report. Med Sci Law. 2008;48:173\u20137.","journal-title":"Med Sci Law"},{"key":"9410_CR11","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2165\/00003495-200161140-00014","volume":"61","author":"MP Curran","year":"2001","unstructured":"Curran MP, Perry CM. Amisulpride: a review of its use in the management of schizophrenia. Drugs. 2001;61:2123\u201350.","journal-title":"Drugs"},{"key":"9410_CR12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hup.320","volume":"17","author":"P Rosenzweig","year":"2002","unstructured":"Rosenzweig P, Canal M, Patat A, Bergougnan L, Zieleniuk I, Bianchetti G. A review of the pharmacokinetics, tolerability and pharmacodynamics of amisulpride in healthy volunteers. Hum Psychopharmacol. 2002;17:1\u201313.","journal-title":"Hum Psychopharmacol"},{"key":"9410_CR13","first-page":"325","volume":"55","author":"R Dorne","year":"2000","unstructured":"Dorne R, Pommier C, Manchon M, Berny C. Intoxication with amisulpride (Solian): a case with toxicologic documentations. Therapie. 2000;55:325\u20138.","journal-title":"Therapie"},{"key":"9410_CR14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1055\/s-2002-31518","volume":"35","author":"R Bottlender","year":"2002","unstructured":"Bottlender R, Jager M, Hofschuster E, Dobmeier P, Moller HJ. Neuroleptic malignant syndrome due to atypical neuroleptics: three episodes in one patient. Pharmacopsychiatry. 2002;35:119\u201321.","journal-title":"Pharmacopsychiatry"},{"issue":"12","key":"9410_CR15","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.4088\/JCP.v65n1219f","volume":"65","author":"EC Atbasoglu","year":"2004","unstructured":"Atbasoglu EC, Ozguven HD, Can Saka M, Goker C. Rhabdomyolysis and coma associated with amisulpride: a probable atypical presentation of neuroleptic malignant syndrome. J Clin Psychiatry. 2004;65(12):1724\u20135.","journal-title":"J Clin Psychiatry"},{"key":"9410_CR16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1176\/appi.neuropsych.19.4.488","volume":"19","author":"E Abay","year":"2007","unstructured":"Abay E, Kose R. Amisulpride-induced neuroleptic malignant syndrome. J Neuropsychiatry Clin Neurosci. 2007;19:488\u20139.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"9410_CR17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00115-007-2343-8","volume":"79","author":"C Harter","year":"2008","unstructured":"Harter C, Obier C, Druschky KF, Eikelmann B. Malignant neuroleptic syndrome associated with amisulpride. Nervenarzt. 2008;79:86\u20139.","journal-title":"Nervenarzt"},{"key":"9410_CR18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/WNF.0b013e3180cfe3a0","volume":"30","author":"V Peritogiannis","year":"2007","unstructured":"Peritogiannis V, Tsouli S, Pappas D, Mavreas V, Konitsiotis S. Neuroleptic malignant syndrome due to amisulpride in a patient with solvent-induced chronic toxic encephalopathy. Clin Neuropharmacol. 2007;30:245\u20136.","journal-title":"Clin Neuropharmacol"},{"key":"9410_CR19","first-page":"536","volume":"34","author":"MC Tu","year":"2011","unstructured":"Tu MC, Hsiao CC. Amisulpride and neuroleptic malignant syndrome. Chang Gung Med J. 2011;34:536\u201340.","journal-title":"Chang Gung Med J"},{"key":"9410_CR20","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1176\/ajp.143.10.1227","volume":"143","author":"HG Pope Jr","year":"1986","unstructured":"Pope HG Jr, Keck PE Jr, McElroy SL. Frequency and presentation of neuroleptic malignant syndrome in a large psychiatric hospital. Am J Psychiatry. 1986;143:1227\u201333.","journal-title":"Am J Psychiatry"},{"issue":"8","key":"9410_CR21","first-page":"1041","volume":"145","author":"PA Adityanjee","year":"1988","unstructured":"Adityanjee PA. The spectrum concept and prevalence of neuroleptic malignant syndrome. Am J Psychiatry. 1988;145(8):1041.","journal-title":"Am J Psychiatry"}],"container-title":["Forensic Science, Medicine, and Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-013-9410-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12024-013-9410-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12024-013-9410-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T15:34:20Z","timestamp":1644593660000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12024-013-9410-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,16]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9410"],"URL":"https:\/\/doi.org\/10.1007\/s12024-013-9410-1","relation":{},"ISSN":["1547-769X","1556-2891"],"issn-type":[{"value":"1547-769X","type":"print"},{"value":"1556-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,16]]}}}